The comparative effect of rabeprazole vs. omeprazole on gastric acid and mucoid-electrolite secretion in patients with peptic ulcer disease

Authors

  • Helena Sklyarova Danylo Halytskyi Lviv National Medical University, Outpatient and Family Department, Ukraine Author
  • Irena Shalko Danylo Halytskyi Lviv National Medical University, Outpatient and Family Department, Ukraine Author

DOI:

https://doi.org/10.12923/

Keywords:

peptic ulcer, rabeprazole, omeprazole

Abstract

Rabeprazole provides superior acid suppression and inhibits pepsin release in comparison to omeprazole. Better ulcer healing results after management by rabeprazole are caused by its gastric mucosa protecting effect in compare with omeprazole.

References

1. Dekkers C.P. et al.: Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre study. The European Rabeprazole Study Group. Aliment. Pharmacol. Ther., 12, 789, 1998.

2. Horn J.: Review article: Relationship between the metabolism and efficacy of proton pump inhibitors—focus on rabeprasole. Aliment Pharmacol. Ther., 20, 9, 2004.

3. Ji S. et al.: Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer disease. J. Gastroenterol. Hepatol., 21, 1381, 2006.

4. Klotz U.: Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. Int. J. Clin. Pharmacol. Ther. 44, 297, 2006.

5. Miner P.Jr. et al.: Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am. J. Gastroenterol., 98, 2616, 2003.

6. Ohning G.V. et al.: Rabeprazole is superior to omeprazole for the inhibition of pepton meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects. Aliment. Pharmacol. Ther., 17, 1109, 2003.

7. Saitoh T. et al.: Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. Aliment. Pharmacol. Ther., 16, 1811, 2002.

8. Sharara A.I.: Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication. Expert. Rev. Anti. Infect. Ther., 3, 863, 2005.

9. Shimatani T. et al.: Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole bu 24-hr intragastric pH-metry. Dig. Dis. Sci., 50, 1202, 2005.

10. Williams M.P.: Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. Aliment. Pharmacol. Ther., 15, 775, 2003.

Downloads

Published

2010-09-30

Issue

Vol. 23 No. 3 (2010): Annales UMCS, Pharmacia, Sectio DDD, Volume XXIII

Section

Artykuły

License

Copyright (c) 2010 Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.